U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07945496) titled 'Bioequivalence of Dapagliflozin and Metformin Extended-release Tablets Versus XIGDUO(R) XR in Healthy Adult Subjects' on Nov. 02.

Brief Summary: This study was conducted to compare a test formulation of dapagliflozin/metformin extended-release tablets (10 mg/1000 mg) with the reference product, XIGDUO XR, in healthy Chinese adults.

The main purpose was to determine whether the two products deliver similar amounts of dapagliflozin and metformin into the bloodstream at a similar rate.

The study included separate groups of participants who received the medications under fasting conditions or fed conditions. In each group, participant...